Summary
Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Argireline is more often discussed in the realm of Dermatology and aesthetics, whereas Semax is more often associated with the realm of Neurology and brain health and Ophthalmology. Both appear to work through Neurotransmitter modulator, but the functional emphasis still separates, with Argireline leaning toward Muscle relaxation and Semax leaning toward Neuroprotection and cognition. Argireline has a more synthetic design origin, while Semax is closer to synthetic analog background and their development context also differs, with Argireline cosmetic grade while Semax is approved for Research use only. Argireline incorporates acetylation features that are not part of Semax.